Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis

Surgery

Volumn 144, Issue 6, 2008, Pages 1044-1051

  Brauckhoff, Michael ^a,b   Machens, Andreas ^a   Hess, Sören ^a   Lorenz, Kerstin ^a   Gimm, Oliver ^c   Brauckhoff, Katrin ^a   Sekulla, Carsten ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF BERGEN   (Norway)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRY EYE; FEMALE; HETEROZYGOTE; HUMAN; INFANT; MALE; MEDICAL INFORMATION; METASTASIS; MISSENSE MUTATION; NEUROFIBROMATOSIS; NEWBORN; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; THYROID MEDULLARY CARCINOMA; THYROID SURGERY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; PROTO-ONCOGENE PROTEINS C-RET; QUESTIONNAIRES; THYROID NEOPLASMS; YOUNG ADULT;

EID: 56449098562     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.08.028     Document Type: Article

References (22)

1. Eng C., Clayton D., Schuffenecker I., Lenoir G., Cote G., Gagel R.F., et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276 (1996) 1575-1579
2. Gimm O., Marsh D.J., Andrew S.D., Frilling A., Dahia P.L., Mulligan L.M., et al. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab 82 (1997) 3902-3904
3. Miyauchi A., Futami H., Hai N., Yokozawa T., Kuma K., Aoki N., et al. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res 90 (1999) 1-5
4. Brauckhoff M., Gimm O., Weiss C.L., Ukkat J., Sekulla C., Brauckhoff K., et al. Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg 28 (2004) 1305-1311
5. Carney J.A., Sizemore G.W., and Hayles A.B. Multiple endocrine neoplasia, type 2b. Pathobiol Annu 8 (1978) 105-153
6. Cohen M.S., Phay J.E., Albinson C., DeBenedetti M.K., Skinner M.A., Lairmore T.C., et al. Gastrointestinal manifestations of multiple endocrine neoplasia type 2. Ann Surg 235 (2002) 648-654
7. Vasen H.F., van der Feltz M., Raue F., Krusseman A.N., Koppeschaar H.P., Pieters G., et al. The natural course of multiple endocrine neoplasia type 2B. Arch Intern Med 152 (1992) 1250-1252
8. ÓRiordain D.S., ÓBrien T., Crotty T.B., Gharib H., Grant C.S., and van Heerden J.A. Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery 118 (1995) 936-942
9. Leboulleux S., Travagli J.P., Caillou B., Laplanche A., Bidart J.M., Schlumberger M., et al. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome. Cancer 94 (2002) 44-50
10. Wray C.J., Rich T.A., Waguespack S.G., Lee J.E., Perrier N.D., and Evans D.B. Failure to recognize multiple endocrine neoplasia 2B: more common than we think?. Ann Surg Oncol 15 (2008) 293-301
11. Ohyama T., Sato M., Murao K., Kittaka K., Namihira H., Matsubara S., et al. A case of multiple endocrine neoplasia type 2B undiagnosed for many years despite its typical phenotype. Endocrine 15 (2001) 143-146
12. Machens A., Niccoli-Sire P., Hoegel J., Frank-Raue K., van Vroonhoven T.J., Roeher H.D., et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349 (2003) 1517-1525
13. Carney J.A., Sizemore G.W., and Hayles A.V. C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2b. Cancer 44 (1979) 2173-2183
14. Jones B.A., and Sisson J.C. Early diagnosis and thyroidectomy in multiple endocrine neoplasia, type 2b. J Pediatr 102 (1983) 219-223
15. Machens A., Brauckhoff M., Gimm O., and Dralle H. Risk-oriented approach to hereditary adrenal pheochromocytoma. Ann N Y Acad Sci 1073 (2006) 417-428
16. Alves M., Dias A.C., and Rocha E.M. Dry eye in childhood: epidemiological and clinical aspects. Ocul Surf 6 (2008) 44-51
17. Eter N., Klingmüller D., Höppner W., and Spitznas M. Typical ocular findings in a patient with multiple endocrine neoplasia type 2b syndrome. Graefes Arch Clin Exp Ophthalmol 239 (2001) 391-394
18. Kinoshita S., Tanaka F., Ohashi Y., Ikeda M., and Takai S. Incidence of prominent corneal nerves in multiple endocrine neoplasia type 2A. Am J Ophthalmol 111 (1991) 307-311
19. Parker D.G., Robinson B.G., and O'Donnell B.A. External ophthalmic findings in multiple endocrine neoplasia type 2B. Clin Experiment Ophthalmol 32 (2004) 420-423
20. Rohatgi J., Gupta V.P., Mittal S., and Faridi M.M. Onset and pattern of tear secretions in full-term neonates. Orbit 24 (2005) 231-238
21. Johnson M.E., and Murphy P.J. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res 23 (2004) 449-474
22. Dyck P.J., Carney J.A., Sizemore G.W., Okazaki H., Brimijoin W.S., and Lambert E.H. Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis. Ann Neurol 6 (1979) 302-314